Related Experiment Video

Updated: Sep 2, 2026

A Customizable Approach for the Enzymatic Production and Purification of Diterpenoid Natural Products
07:59

A Customizable Approach for the Enzymatic Production and Purification of Diterpenoid Natural Products

Published on: October 4, 2019

PRODUCTION AND PARTIAL PURIFICATION OF ANTIBIOTIC MATERIALS FORMED BY PHYSARUM GYROSUM

J M CONSIDINE, M F MALLETTE

    Applied Microbiology
    |May 1, 1965
    PubMed

    Insights

    Physarum gyrosum slime mold produces compounds that inhibit the growth of several harmful bacteria, including E. coli and S. aureus. Further analysis identified multiple antibiotic fractions, highlighting its potential as a source of novel antimicrobial agents.

    Area of Science:

    • Microbiology
    • Mycology
    • Natural Products Chemistry

    Background:

    • The search for novel antimicrobial compounds is crucial due to rising antibiotic resistance.
    • Slime molds are known producers of bioactive secondary metabolites.

    Purpose of the Study:

    • To investigate the antimicrobial properties of the slime mold Physarum gyrosum.
    • To identify and characterize the compounds responsible for the observed antibacterial activity.

    Main Methods:

    • Pure cultures of Physarum gyrosum were cultivated on agar plates with Escherichia coli.
    • Diffusible materials from the cultures were tested for inhibitory effects against various bacterial species.
    • Paper chromatography and preliminary fractionations were employed to isolate active components.

    Main Results:

    • Physarum gyrosum produced diffusible substances that inhibited the growth of Bacillus subtilis, Bacillus cereus, Escherichia coli, Staphylococcus aureus, and Pseudomonas aeruginosa.
    • At least three distinct active antibiotic fractions were identified through paper chromatography.
    • Preliminary fractionations significantly increased the specific activity of the antibiotic compounds.

    Conclusions:

    • Physarum gyrosum possesses significant antimicrobial activity against a range of pathogenic bacteria.
    • The identified active fractions represent potential sources for the development of new antibiotics.
    • Further research into the chemical structure and mode of action of these compounds is warranted.
    Keywords:
    ANTIBIOTICSBACILLUSBACILLUS SUBTILISCHEMISTRY, ANALYTICALCHROMATOGRAPHYCULTURE MEDIADRUG RESISTANCE, MICROBIALELECTROPHORESISESCHERICHIA COLIEXPERIMENTAL LAB STUDYFUNGIMETABOLISMPSEUDOMONAS AERUGINOSASTAPHYLOCOCCUS

    More Related Videos

    Antibiotic Dereplication Using the Antibiotic Resistance Platform10:49

    Antibiotic Dereplication Using the Antibiotic Resistance Platform

    Published on: October 17, 2019

    Bioprospecting of Extremophilic Microorganisms to Address Environmental Pollution07:20

    Bioprospecting of Extremophilic Microorganisms to Address Environmental Pollution

    Published on: December 30, 2021

    Related Concept Videos

    Production of Antibiotics01:27

    Production of Antibiotics

    Penicillin, one of the earliest and most widely used antibiotics, is produced industrially by the filamentous fungus Penicillium chrysogenum. Large stirred-tank bioreactors ranging from tens to hundreds of thousands of liters maintain tightly controlled temperature, pH, and dissolved oxygen conditions to support fungal metabolism and maximize antibiotic yield. Penicillin is a secondary metabolite, synthesized primarily during the stationary growth phase, which requires a carefully managed...
    Downstream Processing01:29

    Downstream Processing

    Downstream processing begins once fermentation is complete and involves a series of steps to recover and purify products such as acids, vitamins, antibiotics, or proteins.Cell HarvestingFor example, for intracellular protein-based products, the first step is harvesting the cells. This is typically achieved using centrifugation or filtration to separate the cells from the liquid phase.Cell Disruption for Intracellular ProductsIf the target product is intracellular, the harvested cells must be...
    Production of Pharmaceuticals01:30

    Production of Pharmaceuticals

    Industrial insulin production uses genetically engineered E. coli expressing a proinsulin gene controlled by a tryptophan promoter and containing a methionine linker for later cleavage. The cells also carry ampicillin resistance for selective growth. Seed cultures are stored at −80 °C and production begins by thawing a small amount to inoculate starter cultures, which are progressively scaled to a 50,000-L bioreactor. In the bioreactor, E. coli grow in nutrient-rich media under sterile, tightly...